{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-113772","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.922502+00:00","generated_at":"2026-06-09T00:30:06.231657+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Avenue Therapeutics closes $5M public offering of stock and warrants","bullets":["Gross proceeds ~$5.0M; estimated net proceeds ~$4.1M after placement agent fees and expenses.","Offering of 16,633,400 units at $0.3006/unit; each unit has 1 share (or pre-funded warrant) plus two warrants.","Series A warrants exercisable at $0.3006/share for 5 years; Series B warrants same price for 18 months.","Maxim Group LLC and Lake Street Capital Markets served as placement agents; 8% cash fee (4% for affiliates).","Closing occurred November 2, 2023; proceeds expected for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-113772","json":"https://secwatch.observer/filing/0001104659-23-113772.json","markdown":"https://secwatch.observer/filing/0001104659-23-113772.md","text":"https://secwatch.observer/filing/0001104659-23-113772.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923113772/0001104659-23-113772-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923113772/tm2329202d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:30:06.231657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}